Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Use of Polyols in Lyophilized Formulations

Posted on By

SOP for Use of Polyols in Lyophilized Formulations

Standard Operating Procedure for Use of Polyols in Lyophilized Formulations

1) Purpose

This SOP outlines the procedure for incorporating polyols (e.g., mannitol, sorbitol) into lyophilized formulations to enhance stability and act as bulking agents, cryoprotectants, or stabilizers.

2) Scope

This SOP applies to formulation scientists, production operators, and QA personnel involved in the preparation of lyophilized products using polyols.

3) Responsibilities

  • Formulation Scientists: Responsible for selecting appropriate polyols based on the formulation’s stability requirements.
  • Operators: Responsible for incorporating the polyols as outlined in the Batch Manufacturing Record (BMR).
  • QA: Responsible for verifying the incorporation of polyols and ensuring proper documentation.
See also  SOP for Incorporation of Taste-Masking Agents in Lyophilized Products

4) Procedure

4.1 Selection of Polyols

4.1.1 Criteria for Selection

  • 4.1.1.1 Polyols must be compatible with the active ingredient and should not interfere with the lyophilization process. Commonly used polyols include mannitol, sorbitol, and glycerol.

4.2 Incorporation of Polyols

4.2.1 Weighing and Addition

  • 4.2.1.1 Weigh the polyols using a calibrated balance as specified in the BMR.
  • 4.2.1.2 Dissolve or disperse the polyols into the formulation solution, ensuring even distribution.

4.2.2 Mixing and Homogenization

  • 4.2.2.1 Stir the solution using a mechanical stirrer to ensure uniform distribution of the polyols.
  • 4.2.2.2 Homogenize the mixture if required to ensure uniformity.

4.3 Filtration and Filling

  • 4.3.1 Filter the solution using a sterile 0.22-micron filter
and fill into vials for lyophilization as per the BMR.

4.4 Documentation

Record all steps, including the addition of polyols, filtration, and lyophilization parameters, in the Polyol Incorporation Logbook and ensure QA verification.

5) Abbreviations

  • BMR: Batch Manufacturing Record

6) Documents

  • Polyol Incorporation Logbook

7) References

  • Pharmacopoeial guidelines for the use of polyols in lyophilized formulations

8) SOP Version

Version 1.0

Annexure

Polyol Incorporation Logbook Template

Date Polyol Name Batch No. Quantity Operator Initials QA Verification
DD/MM/YYYY Polyol Name Batch Number Quantity (grams) Operator Name QA Initials
           


See also  SOP for Monitoring pH in Lyophilized Formulations
Lyophilized Products Tags:Aseptic lyophilization process SOP, FDA guidelines for lyophilized products, Freeze-drying cycle development SOP, Lyophilized product SOP, Lyophilizer calibration SOP, Moisture content testing in lyophilized products, Pharmaceutical freeze-drying SOP, Quality control SOP for lyophilized drugs, SOP for cryoprotectants in lyophilized formulations, SOP for freeze-dried formulation optimization, SOP for handling lyophilized products, SOP for lyophilization of injectable drugs, SOP for lyophilization process in pharmaceuticals, SOP for lyophilization process validation, SOP for lyophilized antibiotics production, SOP for lyophilized product packaging, SOP for lyophilized product storage, SOP for lyophilized product vial filling, SOP for lyophilized vaccine production, SOP for lyophilizer equipment maintenance, SOP for pharmaceutical freeze-drying validation, SOP for primary drying in lyophilization, SOP for reconstitution of lyophilized drugs, SOP for secondary drying in lyophilization, SOP for stability testing of lyophilized products

Post navigation

Previous Post: SOP for Supercritical Fluid Techniques for Nanoparticle Preparation
Next Post: SOP for Preparation of Liposomes for Gene Delivery

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version